Erste Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $814K | Buy |
|
|||||
|
2025
Q1 | $178K | Hold |
|
|||||
|
2024
Q4 | $265K | Hold |
|
|||||
|
2024
Q3 | $464K | Hold |
|
|||||
|
2024
Q2 | $512K | Hold |
|
|||||
|
2024
Q1 | $597K | Hold |
|
|||||
|
2023
Q4 | $702K | Hold |
|
|||||
|
2023
Q3 | $702K | Hold |
|
|||||
|
2023
Q2 | $904K | Hold |
|
|||||
|
2023
Q1 | $796K | Hold |
|
|||||
|
2022
Q4 | $780K | Sell |
|
|||||
|
2022
Q3 | $1.22M | Hold |
|
|||||
|
2022
Q2 | $1.16M | Buy |
|
|||||
|
2022
Q1 | $1.18M | Buy |
|
|||||
|
2021
Q4 | $1.17M | Buy |
|
|||||
|
2021
Q3 | $1.35M | Hold |
|
|||||
|
2021
Q2 | $1.49M | Hold |
|
|||||
|
2021
Q1 | $708K | Sell |
|
|||||
|
2020
Q4 | $961K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $172K | Buy |
|